SEP 8, 2026 · JOURNAL ARTICLE
Long-term metabolic risks after thyroidectomy and thyroid hormone therapy in thyroid cancer survivors: a nationwide cohort study
Frontiers in Endocrinology
Rigorous nationwide population-based cohort study with large sample, long follow-up, and multivariable adjustment demonstrates clear associations between thyroidectomy/thyroid hormone therapy and multiple metabolic outcomes; not practice-changing because it establishes risk rather than testing an intervention to mitigate it.
Reported
Follow-up duration5, 8, and 10 years
Covariates adjustedage, sex, household income, alcohol consump…